DESIGN & DEVELOPMENT OF NOVEL DRUGS BASED ON A NEW TECHNOLOGY
QBR A/S
PIONEERING SOLUTIONS TO
THE GREATEST THREATS IN MODERN MEDICINE
THERE IS AN URGENT
NEED TO COMBAT VIRAL
INFECTIONS THAT CAN
CAUSE PANDEMICS.
​
THE WORLD IS HEADING
TO A POST-ANTIBIOTIC
ERA IN WHICH COMMON
INFECTIONS COULD ONCE
AGAIN KILL (WHO)
​
QBR A/S is a Danish company developing novel Anti Microbial & Anti Viral Peptides as a new class of drugs in infectious diseases.
QBR is at the forefront of the interface of Physics and Chemistry in drug design, utilizing a ground- breaking Resonant Recognition Model – RRM.
PARTNERSHIPS & IP​
-
AMALNA Consulting (AU), RRM Technology.
-
Loma Linda University Hospital (USA), collaborative reresearch and testing facilities.
-
Ljubljana University (SLO) collaborative research and Lab level 3 testing facilities.
-
Pepscan (NL), collaboration agreement regarding development of GMP grade of Peptide Cov18A.
-
Leukocare (D), development of non-toxic solvents.
-
QBR has cooperation agreement with all parties and is the owner of the patented IP.
QBR Team
IVAN
LONCAREVIC
​
CEO
​
Physics,
Copenhagen University
​
More then 20 years experience as an entrepreneur and as consultant for private sector and universities, developing Innovative companies and research project in bio- physical systems.
PROF. IRENA
COSIC
​
RRM TECHNOLOGY
​
AMALNA Consulting
Australia
Director and founder of AMALNA consulting. Development of RRM model since 1994. Experience in biophysics, biomedical engineering and biomedical signal processing.
PROF. UROS
KRAPEZ
​
VIROLOGY
​
Ljubljana University
Slovenia
​
25 years research in respiratory viral infections, herpesviruses, avian pathogenics, Covid19 virus, more then 105 scientific papers published regarding viral infections.
PROF. HANSEL FLETCHER
​
RESISTANT BACTERIA
​
Loma Linda University Hospital, USA.
​
Assistant Dean;
Microbiology Division; Pharmaceutical Science, molecular genetics and biochemistry of microbial diseases, his research program has been focused on bacterial pathogens and recently resistant bacteria.
PROF. ALEN ALBRETH
​
BIO-CHEMISTRY
​
National Institute of
Chemistry, Slovenia
​
Specialising in liquid chromatography
spectrometry, mass spectrometry, complex biological bio fluids,
analytical method development.....